GSK chief nets 76% pay rise after one year

Share via

Andrew Witty took home more than £8 million in pay and share awards last year.

Mr Witty’s first full year as chief executive of GlaxoSmithKline was marked by
a 76 per cent pay rise to £3.128 million, plus £5 million worth of shares in
GSK — a package that could revive the controversy surrounding the pay of JP
Garnier, his predecessor. Mr Garnier was paid $5.9 million last year,
despite leaving the company in May 2008, because of a share option plan
dating from the time that Glaxo Wellcome merged with SmithKlineBeecham.